文献速递疼痛医学区域麻醉与超声

介入性疼痛医学操作中钆对比剂的隐藏风险:回顾性病历审查

Hidden risk of gadolinium-based contrast agents during interventional pain medicine procedures: a retrospective chart review.
PubMed 文献 · Reg Anesth Pain Med · 2024-10-08

本研究回顾性分析了2019年1月1日至2022年5月1日期间接受轴位脊柱操作并使用钆对比剂的508例患者,共697次硬膜外操作。多数患者过敏标签不完整或定义不清,当前指南不推荐这种做法。

要点

  • 钆对比剂用于轴位脊柱操作时不良事件率为3.3%。
  • 多数过敏标签不完整或与碘过敏无关,指南不推荐换用钆对比剂。
  • 鞘内意外注射钆对比剂可能导致神经毒性事件。

核心结论

  • 在轴位脊柱操作中使用钆对比剂替代碘对比剂存在潜在严重不良事件风险,且缺乏避免碘对比剂的循证依据。

研究设计与样本

  • 回顾性病历审查,纳入2019年1月1日至2022年5月1日期间接受钆对比剂轴位脊柱操作(包括硬膜外类固醇注射、硬膜外血补片和选择性神经根阻滞)的患者508例,共697次硬膜外操作。

主要发现

  • 508例患者中23例出现可能与鞘内钆暴露相关的不良事件,不良事件率为3.3%。
  • 几乎所有患者病历中的过敏标签指导医生换用钆对比剂,但多数标签不完整、定义不清或仅与碘过敏相关而非碘对比剂过敏。

临床怎么用

  • 当前指南不推荐因不完整或定义不清的过敏标签而常规使用钆对比剂替代碘对比剂进行轴位脊柱操作。
  • 临床医生应审慎评估过敏标签,避免无循证依据地换用钆对比剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Epidural steroid injections and epidural blood patches commonly involve the injection of a small amount of radiocontrast media under fluoroscopy to properly identify the target tissue or anatomic space and prevent off-target or intravascular delivery of therapeutic or diagnostic drugs. Iodinated low osmolar non-ionic contrast media is the standard preparation used as it is considered safe and cost-effective, but gadolinium-based preparations have been used as an alternative for patients with an 'iodine'-related or radiocontrast media allergy label to prevent hypersensitivity reactions. The risk of neurotoxic events when gadolinium is inadvertently injected into the intrathecal space has been reported in recent years, raising concerns when gadolinium-based contrast media is used in lieu of iodinated low osmolar non-ionic contrast media. METHODS: A retrospective review was conducted of patients who received gadolinium-based contrast media for procedures with risk of inadvertent intrathecal access from January 1, 2019 to May 1, 2022. Information on patient demographics, allergy label information, and procedure description was documented for all patients who received gadolinium-based contrast media for axial spine procedures (including epidural steroid injections, epidural blood patch procedures, and selective nerve root blocks), and all side effects reported within 1 month of the procedure were recorded. Saved fluoroscopy images of all procedures for which there was concern for possible gadolinium-based contrast media-related side effect were reviewed for evidence of inadvertent intrathecal gadolinium-based contrast media administration. Descriptive statistical analysis was performed using REDCap and IBM SPSS Statistics V.28. RESULTS: We identified 508 patients who received gadolinium-based contrast media during a fluoroscopically guided axial spine procedure. These patients underwent 697 epidural procedures and 23 patients were identified as experiencing an adverse event that could be consistent with possible, probable, or clear signs of exposure to intrathecal gadolinium. Our calculated adverse event rate was 3.3%. Ten patients required additional medical evaluation or treatment. DISCUSSION: Almost all patients in our cohort had an allergy label on their chart that guided the provider to switch to gadolinium-based contrast media, but most were incomplete, ill-defined, or related to allergy to iodine but not iodinated contrast media. Such practice is not recommended based on current guidelines. The current study raises concern regarding the use of gadolinium-based contrast media in axial spine procedures, with the risk of potential severe adverse events, without evidence-based need for avoiding iodinated contrast media.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hallo-Carrasco A, Eldrige J, Provenzano DA, et al. Hidden risk of gadolinium-based contrast agents during interventional pain medicine procedures: a retrospective chart review. Reg Anesth Pain Med. 2024. PMID: 37951601. doi:10.1136/rapm-2023-104952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。